Tobacco harm reduction: How rational public policy could transform a pandemic

References 

1. Brandt AM. No magic bullet: A social history of venereal disease in the United States since 1880. Oxford University Press; 1987;
2. Fagerstrom K. The nicotine market: An attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries. Nicotine & Tobacco Research. 2005, June;7(3):343–350
3. Gray N, Henningfield J. Dissent over harm reduction for tobacco. Lancet. 2006, September 9;368:899–901
   • Full Text
   • Full-Text PDF (47 KB)
   • CrossRef
4. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiology, Biomarkers & Prevention. 2004;13:2035–2042
5. Meier, B., & Shelley, D. (2006, September–October). The fourth pillar of the framework convention on tobacco control: Harm reduction and the international human right to health (Vol. 121, pp. 494–500). Public Health Reports.
6. Morgan Stanley Research North America. (2006, September 19). UST: Further from the precipice, but still significant L-T issues. Morgan Stanley.
7. Peto R, Lopez AD. Future worldwide health effects of current smoking patterns. In:  Koop CE,  Pearson C,  Schwarz MR editor. Critical issues in global health. San Francisco: Jossey-Bass; 2001;p. 154–158
8. Tobacco Advisory Group of the Royal College of Physicians (2002). Protecting smokers, saving lives: The case for a Tobacco and Nicotine Authority, London.
9. Young JH. Pure food: Securing the Federal Food and Drugs Act of 1906.. Princeton University Press; 1989;